NCT05781360
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05781360
Title A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jiangsu Simcere Pharmaceutical Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis Indiana 46202 United States Details
NYU Langone New York New York 10016 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Anhui Provincial Hospital Hefei Anhui 230061 China Details
Fujian Cancer Hospital Fuzhou Fujian 350014 China Details
Henan Cancer Hospital Zhengzhou Henan 450003 China Details
Hunan Cancer Hospital Changsha Hunan 410031 China Details
Shandong Cancer Hospital Jinan Shandong 250117 China Details
The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang 310003 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field